feed,title,long_url,short_url
SeekingAlpha,Oncolytics Biotech gets dosing underway in phase 1/2 pelareorep/atezolizumab cancer trial,https://seekingalpha.com/news/3763744,
SeekingAlpha,"Astec EPS beats by $0.19, beats on revenue",https://seekingalpha.com/news/3763748,
SeekingAlpha,Centene sells majority stake in U.S. Medical Management,https://seekingalpha.com/news/3763746,
SeekingAlpha,"Evo Payments EPS misses by $0.09, beats on revenue",https://seekingalpha.com/news/3763747,
SeekingAlpha,"New York Times EPS beats by $0.02, beats on revenue",https://seekingalpha.com/news/3763745,
SeekingAlpha,"KKR to acquire food processing equipment provider, Bettcher Industries",https://seekingalpha.com/news/3763743,
SeekingAlpha,"Superior EPS misses by $0.28, misses on revenue",https://seekingalpha.com/news/3763742,
